Vitamin D protects against hippocampal apoptosis related with seizures induced by kainic acid and pentylenetetrazol in rats
dc.contributor.author | Şahin S. | |
dc.contributor.author | Gürgen S.G. | |
dc.contributor.author | Yazar U. | |
dc.contributor.author | İnce İ. | |
dc.contributor.author | Kamaşak T. | |
dc.contributor.author | Acar Arslan E. | |
dc.contributor.author | Diler Durgut B. | |
dc.contributor.author | Dilber B. | |
dc.contributor.author | Cansu A. | |
dc.date.accessioned | 2024-07-22T08:09:11Z | |
dc.date.available | 2024-07-22T08:09:11Z | |
dc.date.issued | 2019 | |
dc.description.abstract | Objectives: The hippocampus is susceptible to damage in patients with epilepsy and in animals with seizures caused by excitotoxic agents. The effect of vitamin D on hippocampal apoptosis related with seizures has not been reported. However, epileptic patients have an increased risk of hypovitaminosis D which is most likely due to the effects of antiepileptic drugs. Therefore, in this study, it was aimed to evaluate the effects of vitamin D on hippocampal apoptosis related with seizures by using pentylenetetrazol (PTZ) and kainic acid (KA) in rats. Methods: Male Sprague Dawley rats, aged 5.5 weeks, were randomly divided into six groups: control, vitamin D, PTZ, KA, PTZ + vitamin D and KA + vitamin D groups. The groups that received vitamin D were given 500 IU/kg of vitamin D daily for two weeks in addition to a standard diet. At the end of this period, PTZ and KA were applied to trigger seizures in the rats in the seizure groups. 24 h after the administration of PTZ and KA, the rats were decapitated. In the hippocampal region, apoptosis was assessed by TUNEL and brain-derived neurotrophic factor (BDNF), Bax, caspase-3 and c-fos activation were evaluated by immunohistochemical method. Results: BDNF level increased while c-fos, Bax and caspase-3 levels decreased (p < 0.0001, in all) in the hippocampal neurons of the groups that were pre-treated with vitamin D before the administration of PTZ and KA, in comparison with the PTZ and KA groups. Vitamin D significantly decreased the number of apoptotic cells in these rats in comparison with the PTZ and KA groups (p < 0.0001). Conclusion: This study indicates that vitamin D has neuroprotective effects on hippocampal apoptosis induced by PTZ and KA in rats. With this study it is suggested that keeping vitamin D levels within normal limits may be beneficial for patients with epilepsy, especially children. © 2018 Elsevier B.V. | |
dc.identifier.DOI-ID | 10.1016/j.eplepsyres.2018.12.005 | |
dc.identifier.issn | 09201211 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/14710 | |
dc.language.iso | English | |
dc.publisher | Elsevier B.V. | |
dc.subject | Animals | |
dc.subject | Apoptosis | |
dc.subject | bcl-2-Associated X Protein | |
dc.subject | Brain-Derived Neurotrophic Factor | |
dc.subject | Caspase 3 | |
dc.subject | Convulsants | |
dc.subject | Disease Models, Animal | |
dc.subject | Hippocampus | |
dc.subject | In Situ Nick-End Labeling | |
dc.subject | Kainic Acid | |
dc.subject | Male | |
dc.subject | Neurons | |
dc.subject | Neuroprotective Agents | |
dc.subject | Pentylenetetrazole | |
dc.subject | Proto-Oncogene Proteins c-fos | |
dc.subject | Rats | |
dc.subject | Rats, Sprague-Dawley | |
dc.subject | Seizures | |
dc.subject | Vitamin D | |
dc.subject | brain derived neurotrophic factor | |
dc.subject | caspase 3 | |
dc.subject | devit 3 | |
dc.subject | protein Bax | |
dc.subject | vitamin D | |
dc.subject | brain derived neurotrophic factor | |
dc.subject | caspase 3 | |
dc.subject | convulsant agent | |
dc.subject | kainic acid | |
dc.subject | neuroprotective agent | |
dc.subject | pentetrazole | |
dc.subject | protein Bax | |
dc.subject | protein c fos | |
dc.subject | vitamin D | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | animal tissue | |
dc.subject | apoptosis | |
dc.subject | Article | |
dc.subject | controlled study | |
dc.subject | drug efficacy | |
dc.subject | enzyme activation | |
dc.subject | hippocampal CA3 region | |
dc.subject | hippocampus | |
dc.subject | immunohistochemistry | |
dc.subject | kainic acid-induced seizure | |
dc.subject | male | |
dc.subject | neuroprotection | |
dc.subject | nonhuman | |
dc.subject | outcome assessment | |
dc.subject | pentylenetetrazole-induced seizure | |
dc.subject | priority journal | |
dc.subject | protein expression | |
dc.subject | randomized controlled trial | |
dc.subject | rat | |
dc.subject | TUNEL assay | |
dc.subject | animal | |
dc.subject | apoptosis | |
dc.subject | chemically induced | |
dc.subject | disease model | |
dc.subject | drug effect | |
dc.subject | hippocampus | |
dc.subject | metabolism | |
dc.subject | nerve cell | |
dc.subject | pathology | |
dc.subject | seizure | |
dc.subject | Sprague Dawley rat | |
dc.title | Vitamin D protects against hippocampal apoptosis related with seizures induced by kainic acid and pentylenetetrazol in rats | |
dc.type | Article |